FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $813,173 | +19.7% | 183,147 | -11.1% | 0.00% | – |
| Q2 2023 | $679,625 | -75.3% | 205,947 | -78.7% | 0.00% | – |
| Q1 2023 | $2,751,926 | -75.8% | 965,588 | -38.1% | 0.00% | – |
| Q4 2022 | $11,362,828 | +93.6% | 1,560,828 | +115.1% | 0.00% | – |
| Q3 2022 | $5,869,000 | +84.7% | 725,517 | +11.8% | 0.00% | – |
| Q2 2022 | $3,178,000 | -80.1% | 648,666 | -4.0% | 0.00% | -100.0% |
| Q1 2022 | $15,986,000 | +29.5% | 675,954 | -3.1% | 0.00% | 0.0% |
| Q4 2021 | $12,346,000 | -3.2% | 697,911 | +54.3% | 0.00% | 0.0% |
| Q3 2021 | $12,760,000 | +290.0% | 452,312 | +44.9% | 0.00% | – |
| Q2 2021 | $3,272,000 | +9.1% | 312,225 | +22.7% | 0.00% | – |
| Q1 2021 | $2,998,000 | +6.9% | 254,497 | +6.3% | 0.00% | – |
| Q4 2020 | $2,804,000 | +66.7% | 239,449 | +12.9% | 0.00% | – |
| Q3 2020 | $1,682,000 | -55.6% | 212,055 | +2.4% | 0.00% | – |
| Q2 2020 | $3,788,000 | +63.3% | 207,098 | +6.6% | 0.00% | – |
| Q1 2020 | $2,319,000 | +256.8% | 194,262 | +397.5% | 0.00% | – |
| Q4 2019 | $650,000 | – | 39,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |